<?xml version="1.0" encoding="UTF-8"?>
<p>The inflammation-associated cognitive decline is mainly due to degeneration of central cholinergic neurons or cholinergic impairment, making acetylcholinesterase inhibitors the main class of drugs currently used in the treatment of mild cognitive impairment and Alzheimer’s disease (
 <xref rid="B25" ref-type="bibr">Benfante et al., 2019</xref>). In a study by 
 <xref rid="B125" ref-type="bibr">Ndhlala et al. (2011)</xref>, an aqueous extract of the roots of 
 <italic>E. cordatum</italic> with an IC
 <sub>50</sub> value of 756.6 μg/ml showed a very low acetyl cholinesterase inhibitory activity.
</p>
